Lexicon Announces Telotristat Etiprate Data To Be Presented At North American Neuroendocrine Tumor Society Annual Symposium
October 09, 2015 at 08:01 AM EDT
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that data from the TELESTAR Phase 3 clinical study of telotristat etiprate ...